Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus

Neuroscience Letters

Volumn 331, Issue 2, 2002, Pages 123-127

  Mazarati, Andrey M ^a,b   Wasterlain, Claude G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dynorphin A (1 13); Galanin; Hippocampus; Neuropeptide; Neuropeptide Y; Somatostatin; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; DYNORPHIN A; GALANIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PEPTIDE; SODIUM CHLORIDE; SOMATOSTATIN;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SEIZURE;

ANIMALS; DENTATE GYRUS; DYNORPHINS; ELECTROENCEPHALOGRAPHY; GALANIN; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDE Y; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PERFORANT PATHWAY; RATS; RATS, WISTAR; SOMATOSTATIN; STATUS EPILEPTICUS; TIME FACTORS;

EID: 0037064229     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00847-9     Document Type: Article

References (20)

1. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:1997;8927-8936.
2. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol. Sci. 21:2000;109-117.
3. Drake C.T., Terman G.W., Simmons M.L., Milner T.A., Kunkel D.D., Schwartzkroin P.A., Chavkin C. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J. Neurosci. 14:1994;3736-3750.
4. Gariboldi M., Conti M., Cavaleri D., Samanin R., Vezzani A. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur. J. Neurosci. 10:1998;757-759.
5. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113:1994;737-740.
6. Harrison M.B., Shumate M.D., Lothman E.W. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience. 65:1995;785-795.
7. Marksteiner J., Ortler M., Bellmann R., Sperk G. Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy of the rat. Neurosci. Lett. 112:1990;143-148.
8. Mazarati A., Liu H., Wasterlain C. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus. Neuroscience. 89:1999;167-173.
9. Mazarati A.M., Langel U.L., Bartfai T. Galanin: an endogenous anticonvulsant? Neuroscientist. 7:2001;508-519.
10. Mazarati A.M., Wasterlain C.G. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci. Lett. 265:1999;187-190.
11. Patrylo P.R., van den Pol A.N., Spencer D.D., Williamson A. NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J. Neurophysiol. 82:1999;478-483.
12. Perez J., Vezzani A., Civenni G., Tutka P., Rizzi M., Schupbach E., Hoyer D. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience. 65:1995;1087-1097.
13. 2+ entry. J. Neurosci. 17:1997;8169-8177.
14. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 69:1995;831-845.
15. Sperk G., Herzog H. Anticonvulsant action of neuropeptide Y: neuropeptide Y may act as an endogenous anticonvulsant through Y5 receptors suggesting a new target for antiepileptic drugs [news; comment]. Nat. Med. 3:1997;728-729.
16. Tallent M.K., Siggins G.R. Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity. J. Neurophysiol. 81:1999;1626-1635.
17. Vezzani A., Bendotti C., Rizzi M., Monno A., Tarizzo G., Samanin R. Functional activation of somatostatin and neuropeptide Y containing neurons in experimental models of limbic seizures. Epilepsy Res. 12:(Suppl.):1996;187-195.
18. Vezzani A., Civenni G., Rizzi M., Monno A., Messali S., Samanin R. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 660:1994;138-143.
19. Vezzani A., Hoyer D. Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. Eur. J. Neurosci. 11:1999;3767-3776.
20. Zini S., Roisin M.P., Langel U., Bartfai T., Ben-Ari Y. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur. J. Pharmacol. 245:1993;1-7.